Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for IV-PCA after cesarean section
ChiCTR2500110374Phase 4Not yet recruiting
- Sponsor
- Yongzhou Central Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Yongzhou Central Hospital. Primary endpoints: Numeric Rating Scale score, Ramsay Sedation Scale score and 2 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500110374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110374.